Much of the information on this website has recently been updated according to changes in regulations from January 1 2018​.

 

 

Horizon scanninghttps://legemiddelverket.no/english/public-funding-and-pricing/horizon-scanningHorizon scanningHorizon scanning shall ensure that new and important health technologies are identified and prioritised for health technology assessment.1941
Pipeline meetingshttps://legemiddelverket.no/english/public-funding-and-pricing/pipeline-meetingsPipeline meetingsThe Norwegian Medicines Agency are continually striving to map new drugs and indications expected to be launched in Norway in the foreseeable future. This is done through horizon scanning reports (early alerts) and pipeline meetings.1951
Submission of documentation for single technology assessment of pharmaceuticalshttps://legemiddelverket.no/english/public-funding-and-pricing/documentation-for-staSubmission of documentation for single technology assessment of pharmaceuticalsAll new pharmaceuticals with Marketing Authorisation are subject to a single technology assessment (STA) before they can be funded by the public sector - either by the hospitals or under the National Insurance Scheme (“folketrygden”). 1932Guidelines and template for documentation.
Single technology assessments - status and reportshttps://legemiddelverket.no/english/public-funding-and-pricing/single-technology-assessments-status-and-reportsSingle technology assessments - status and reportsThe current status of single technology assessments (STAs) and a list of STA reports.1940
Maximum pricehttps://legemiddelverket.no/english/public-funding-and-pricing/maximum-priceMaximum priceHere you will find information about price applications and reevaluation of prices. 782
The Norwegian health care system and pharmaceutical systemhttps://legemiddelverket.no/english/about-us/the-norwegian-health-care-system-and-pharmaceutical-systemThe Norwegian health care system and pharmaceutical systemAn introcuction for foreigners with a comprehensive presentation of the pharmaceutical system, pricing and reimbursement in Norway.436

​Fant du det du lette etter?